Oncternal Therapeutics Inc (ONCT) — Financial Flexibility Index
Oncternal Therapeutics Inc (ONCT) has a Financial Flexibility Index of -1.08x as of September 2024. Free cash flow of $-6.95 Million (operating CF $-6.95 Million minus capex $0.00) represents -1% of total liabilities ($6.45 Million). Check how aggressively does Oncternal Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncternal Therapeutics Inc Financial Flexibility Index (2002–2023)
Historical Financial Flexibility Index trend for Oncternal Therapeutics Inc across 22 annual periods. For the full cash flow conversion analysis, see Oncternal Therapeutics Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Oncternal Therapeutics Inc (2002–2023)
Year-by-year free cash flow to debt coverage for Oncternal Therapeutics Inc. Explore Oncternal Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -4.82x | $-32.16 Million | $-32.16 Million | $6.68 Million | ▼ -0.8% |
| 2022 | -4.78x | $-36.70 Million | $-36.70 Million | $7.68 Million | ▲ +1.8% |
| 2021 | -4.87x | $-26.59 Million | $-26.59 Million | $5.46 Million | ▼ -62.9% |
| 2020 | -2.99x | $-17.50 Million | $-17.50 Million | $5.86 Million | ▼ -32.5% |
| 2019 | -2.25x | $-16.75 Million | $-16.75 Million | $7.43 Million | ▲ +70.2% |
| 2018 | -7.55x | $-39.35 Million | $-39.35 Million | $5.21 Million | ▼ -156.7% |
| 2017 | -2.94x | $-23.46 Million | $-23.46 Million | $7.97 Million | ▲ +34.4% |
| 2016 | -4.49x | $-20.69 Million | $-20.78 Million | $4.61 Million | ▼ -575.8% |
| 2015 | -0.66x | $-20.03 Million | $-20.04 Million | $30.17 Million | ▲ +24.2% |
| 2014 | -0.88x | $-28.75 Million | $-28.76 Million | $32.82 Million | ▲ +90.2% |
| 2013 | -8.93x | $-43.94 Million | $-43.97 Million | $4.92 Million | ▼ -143.3% |
| 2012 | -3.67x | $-36.97 Million | $-37.11 Million | $10.07 Million | ▲ +29.9% |
| 2011 | -5.24x | $-33.03 Million | $-33.09 Million | $6.31 Million | ▼ -115.4% |
| 2010 | -2.43x | $-30.43 Million | $-30.53 Million | $12.52 Million | ▼ -255.8% |
| 2009 | -0.68x | $-45.40 Million | $-46.00 Million | $66.47 Million | ▼ -259735.4% |
| 2008 | 0.00x | $-20.00K | $-2.92 Million | $76.09 Million | ▲ +99.9% |
| 2007 | -0.44x | $-35.90 Million | $-37.63 Million | $80.81 Million | ▼ -31.5% |
| 2006 | -0.34x | $-10.88 Million | $-11.46 Million | $32.21 Million | ▲ +90.8% |
| 2005 | -3.67x | $-33.88 Million | $-34.82 Million | $9.23 Million | ▼ -132.2% |
| 2004 | -1.58x | $-14.50 Million | $-15.67 Million | $9.17 Million | ▼ -1954.3% |
| 2003 | -0.08x | $-12.89 Million | $-13.00 Million | $167.54 Million | ▲ +50.9% |
| 2002 | -0.16x | $-10.24 Million | $-10.55 Million | $65.34 Million | — |